(a) There is a technical advisory committee to the Program.
(b) The purpose of the technical advisory committee is to:
(1) Review requests for information from the Program under § 21–2A–06(b)(3), (4), (5), (8), or (9) of this subtitle; and
(2) Provide clinical guidance and interpretation to the Program regarding indications of possible misuse or abuse of a monitored prescription drug or a possible violation of law or a possible breach of professional standards by a prescriber or a dispenser under § 21–2A–06(c) and (d) of this subtitle.
(c) The technical advisory committee consists of members appointed by the Secretary, including:
(1) A board certified anesthesiologist licensed and practicing in the State, nominated by the Maryland Society of Anesthesiologists;
(2) A certified addiction medicine specialist licensed and practicing in the State, nominated by the Maryland Society for Addiction Medicine;
(3) A pharmacist licensed and practicing in the State;
(4) A medical professional, licensed and practicing in the State, who is treating cancer patients;
(5) A board certified physician specializing in the treatment of patients with pain, licensed and practicing in the State, nominated by the Maryland Society of Physical Medicine and Rehabilitation;
(6) Two medical professionals, licensed and practicing in the State with expertise or experience in providing care for patients with substance–related or mental health disorders;
(7) A dentist licensed and practicing in the State; and
(8) A medical professional licensed and practicing in the State in the field of internal medicine or family practice.